美股市場個股詳情
KNSA Kiniksa Pharmaceuticals International
- 21.100
- -0.110-0.52%
交易中 11/21 13:36 (美東)
15.23億總市值-175833市盈率TTM
21.380最高價20.710最低價10.20萬股成交量21.270今開21.210昨收213.88萬成交額0.61%換手率105.50市盈率(靜)7220.16萬總股本28.15052周最高3.49市淨率3.56億流通值15.52052周最低--股息TTM1685.19萬流通股32.880歷史最高--股息率TTM3.16%振幅5.010歷史最低20.958平均價1股每手
關於Kiniksa Pharmaceuticals International公司
Kiniksa Pharmaceuticals International PLC是一家處於臨牀階段的生物製藥公司，致力於發現、收購、開發和商業化治療衰弱性疾病患者的藥物。該公司處於臨牀階段的候選產品包括利納西普、abiprubart、瑪弗利木單抗。
公司介紹
公司代碼KNSA
公司名稱Kiniksa Pharmaceuticals International
上市日期2018/05/24
發行價格18.00
成立日期2024
CEOMr. Sanj K. Patel
所屬市場納斯達克
員工數量297
年結日12-31
公司地址23 Old Bond Street,3rd Floor
城市倫敦
省份大倫敦
國家英國
郵編W1S 4PZ
電話44-781-431-9100
董事高管
- 姓名
- 職務
- 年薪
- Sanj K. Patel
- Chief Executive Officer and Chairman of the Board
- 529.71萬
- Ross Moat
- Senior Vice President and Chief Commercial Officer
- --
- Mark Ragosa
- Senior Vice President and Chief Financial Officer
- --
- John F. Paolini, M.D.,PhD
- Senior Vice President and Chief Medical Officer
- 178.91萬
- Michael R. Megna
- Chief Accounting Officer and Group Vice President, Finance
- --
- Eben Tessari
- Senior Vice President and Chief Operating Officer
- 175.21萬
- Cantey Boyd
- Director
- --
- Dr. Richard S. Levy,M.D.
- Independent Director
- 45.97萬
- Tracey L. McCain, Esq.
- Independent Director
- 36.54萬
- Kimberly J. Popovits
- Independent Director
- 36.27萬
- G. Bradley Cole
- Independent Director
- 36.54萬
- Dr. Felix J. Baker,PhD
- Lead Independent Director
- 41.11萬
- Dr. Barry D. Quart,Pharm.D.
- Independent Director
- 37.26萬
- Dr. Stephen R. Biggar,M.D.,PhD
- Independent Director
- 37.20萬
- Thomas R. Malley
- Independent Director
- 38.04萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據